Schrödinger (SDGR) Stock Analysis

What Schrödinger does

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Key metrics

ETFs linked to SDGR

Broad-market and Technology sector ETFs an investor holding Schrödinger is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SDGR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Schrödinger?

Schrödinger trades under the ticker SDGR on NASDAQ.

Which exchange is SDGR listed on?

SDGR is listed on NASDAQ.

What sector does Schrödinger operate in?

Schrödinger is classified in the Technology sector (Software - Application industry).

How can PortView help analyze SDGR in a portfolio?

PortView shows SDGR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.